Scientists discover how antibiotic molecule found in bacteria stops breast cancer
Scientists have discovered how a molecule that was first discovered in bacteria blocks a protein which causes breast cancer to develop and spread, reveals research published in Nature Chemistry today.
Scientists at Cancer Research UK’s Cambridge Research Institute, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and The University of Cambridge, have revealed at the molecular level how thiostrepton - a naturally-occurring cancer-protector molecule - ‘clamps’ a cancer-causing protein called FOXM1, preventing it from working.
FOXM1 is present in greater amounts in breast cancer cells. It attaches to specific stretches of DNA - switching on genes regulating the growth and division of cells. It also causes tumours to spread and triggers the growth of blood vessels which supply tumours with nutrients for growth.
Blocking this protein may prevent the development of cancer at an early stage as well as block cancer growth and spread.
Designing drugs to stop proteins like FOXM1 is a huge challenge for scientists. But this new information will allow researchers to design small molecules that mimic thiostrepton – but are even more effective at blocking the cancer-promoting effects of FOXM1.
Lead author, Professor Shankar Balasubramanian, based at Cancer Research UK’s Cambridge Research Institute, said: “Before this research we weren’t aware of any natural product which could directly target a protein that controls gene activity. Yet intriguingly a molecule in bacteria - which also has strong antibiotic effects - does this very well, switching off cancer-causing genes in breast cancer cells.
“This naturally-occurring molecule doesn’t have all the right properties to be used as a breast cancer treatment itself. But this exciting discovery paves the way for the design of more potent and selective drugs based on the structure of thiostrepton to block the FOXM1 protein.”
Around 48,000 women in the UK are diagnosed with breast cancer each year and around 12,100 UK women die from the disease.
Dr Lesley Walker, Cancer Research UK’s director of cancer information, said: “Survival rates for breast cancer have been improving for 30 years thanks to the development of more targeted treatments. But there is more to be done. One huge challenge is how to prevent breast cancer from spreading to other parts of the body – once a cancer has spread it becomes more difficult to treat successfully.
“It’s fascinating to discover how a simple bacteria could hold the key to powerful new approaches to treat breast cancer developing and spreading.”
For media enquiries please contact the press office on 020 3469 8300 or, out-of-hours, the duty press officer on 07050 264 059.
The transcription factor FOXM1 is a cellular target of the natural product thiostrepton. Hegde et al. Nature Chemistry.